Company: OFIX
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026066
Chunk: 69

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 16
Chunk 69
---
        3.38% – 4.61%

        —

        Dividend yield

        —

        —

        —

        Weighted average grant date fair value
         
        $
        5.90

        $
        8.43

        $
        —

      The expected term of the options granted is estimated based on a number of factors, including the vesting and expiration terms of the award, historical employee exercise behavior for both options that are currently outstanding and options that have been exercised or are expired, and an employee’s average length of service. Expected volatility is based on the historical volatility of the Company’s common stock. The risk-free interest rate is determined based upon a constant U.S. Treasury security rate with a contractual life that approximates the expected term of the option. 

F-36

Certain of the Company's outstanding stock options contain market-based vesting conditions. The fair value of market-based stock options is determined at the date of the grant using the Monte Carlo valuation methodology. The Monte Carlo methodology incorporates into the valuation the possibility that the market condition may not be satisfied. Such value is recognized over the three-year service period, net of actual forfeitures.A summary of the status of the Company’s time-based stock option plans as of December 31, 2024, and 2023, and changes during the year ended December 31, 2024, is presented below:

        (In thousands)
         
        Options

        WeightedAverageExercisePrice

        WeightedAverageRemainingContractualTerm (Years)

        Outstanding at December 31, 2023

        3,223

        $
        30.64

        Granted

        773

        $
        13.54

        Exercised

        (12
        )
         
        $
        14.69

        Forfeited or expired

        (787
        )
         
        $
        32.31

        Outstanding at December 31, 2024

        3,197

        $
        26.15

        4.52

        Vested and expected to vest at December 31, 2024

        3,197

        $
        26.15

        4.52

        Exercisable at December 31, 2024

        2,119

        $
        30.84

        3.32

       A summary of the status of the Company’s market-based stock option